Özcan Deveci
About
In The Last Decade
Özcan Deveci
34 papers receiving 323 citations
Peers
Comparison fields: 5 of 81
- Epidemiology 146
- Infectious Diseases 47
- Small Animals 44
- Molecular Biology 43
- Applied Microbiology and Biotechnology 42
Countries citing papers authored by Özcan Deveci
This map shows the geographic impact of Özcan Deveci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özcan Deveci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özcan Deveci more than expected).
Fields of papers citing papers by Özcan Deveci
This network shows the impact of papers produced by Özcan Deveci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özcan Deveci. The network helps show where Özcan Deveci may publish in the future.
Co-authorship network of co-authors of Özcan Deveci
This figure shows the co-authorship network connecting the top 25 collaborators of Özcan Deveci. A scholar is included among the top collaborators of Özcan Deveci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özcan Deveci. Özcan Deveci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 12 | |
| 5 | Non-invasive parameters in the assessment of liver fibrosis | 2 |
| 6 | 11 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 35 | |
| 10 | Tenofovir disoproxil fumarate treatment in HbeAg-positive patients. | 1 |
| 11 | 5 | |
| 12 | 10 | |
| 13 | 32 | |
| 14 | 22 | |
| 15 | 17 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | 2 | |
| 19 | 4 | |
| 20 | Nanotıp, mikrodizilimler ve klinik mikrobiyolojide kullanımları | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.